Co-infections in people with COVID-19: a systematic review and meta-analysis

World Health Organization. Coronavirus Disease (COVID-19) pandemicAvailable from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 13 May 2020

Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8

Zhu, 2020, A Novel Coronavirus from Patients with Pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017

Guan, 2020, Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032

Wu, 2020, Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med, 10.1001/jamainternmed.2020.0994

Feng, 2020, COVID-19 with Different Severity: A Multi-center Study of Clinical Features, Am J Respir Crit Care Med, 10.1164/rccm.202002-0445OC

Joseph, 2013, Bacterial and viral infections associated with influenza, Influenza Other Respir Viruses, 7, 105, 10.1111/irv.12089

Assiri, 2013, Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study, Lancet Infect Dis, 13, 752, 10.1016/S1473-3099(13)70204-4

Zahariadis, 2006, Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays, Can Resp J, 13, 17

Wang, 2020, Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China, Clin Infect Dis

Du, 2020, Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China

Wan, 2020, Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing, J Med Virol., 10.1002/jmv.25783

Xia, 2020, Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults, Pediatr Pulmonol, 55, 1169, 10.1002/ppul.24718

World Health Organization. Antimicrobial resistance factsheet 2018Available from: https://www.who.int/en/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 13 May 2020

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535

Wells G, Shea B, O'Connell D, Peterson J, V Welch, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysesAvailable from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 13 May 2020

Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366, l4898, 10.1136/bmj.l4898

Lansbury, 2020, Co-infections in people with COVID-19: a systematic review and meta-analysis, PROSPERO

Cao, 2020, A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282

Arentz, 2020, Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State, JAMA, 10.1001/jama.2020.4326

Barrasa, 2020, SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria, Anaesth Crit Care Pain Med, 10.1016/j.accpm.2020.04.001

Bhatraju, 2020, Covid-19 in Critically Ill Patients in the Seattle Region - Case Series, N Engl J Med, 10.1056/NEJMoa2004500

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7

Ding, 2020, The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China, J Med Virol., 10.1002/jmv.25781

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, 395, 497

Lian, 2020, Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan, Clin Infect Dis, 10.1093/cid/ciaa242

Lin, 2020, Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients, Sci China Life Sci, 63, 606, 10.1007/s11427-020-1668-5

Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci China Life Sci, 63, 364, 10.1007/s11427-020-1643-8

Mo, 2020, Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis., 10.1093/cid/ciaa270

Pongpirul, 2020, Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand, Emerg Infect Dis, 26, 10.3201/eid2607.200598

Tagarro, 2020, Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain, JAMA Pediatr.

Wang, 2020, Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up, J Infect, 10.1016/j.jinf.2020.03.019

Wang, 2020, Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China, J Infect Dis., 221, 1770, 10.1093/infdis/jiaa119

Wu, 2020, Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study, Clin Infect Dis

Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5

Young, 2020, Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore, JAMA, 10.1001/jama.2020.3204

Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy, 10.1111/all.14238

Zhao, 2020, A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias, Clin Infect Dis

Zheng, 2020, Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China, Curr Med Sci, 40, 275, 10.1007/s11596-020-2172-6

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x

Kim, 2020, Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens, JAMA, 10.1001/jama.2020.6266

MacIntyre, 2018, The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09, BMC Infect Dis, 18, 637, 10.1186/s12879-018-3548-0

Chertow, 2013, Bacterial coinfection in influenza: a grand rounds review, JAMA, 309, 275, 10.1001/jama.2012.194139

Klein, 2016, The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis, Influenza Other Respir Viruses, 10, 394, 10.1111/irv.12398

Arabi, 2017, Middle East Respiratory Syndrome, N Engl J Med, 376, 584, 10.1056/NEJMsr1408795

Hwang, 2005, Pulmonary pathology of severe acute respiratory syndrome in Toronto, Mod Pathol, 18, 1, 10.1038/modpathol.3800247

Sobieszczanska, 2014, Relevance of serology for Mycoplasma pneumoniae infection among children with persistent cough, Adv Clin Exp Med, 23, 185, 10.17219/acem/37046

Jones, 2010, Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, Clin Infect Dis, 51, S81, 10.1086/653053

Alanio A, Dellière S, Fodil S, Bretagne S, B.M. High Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 Patients (April 14, 2020) Available from: SRN:https://ssrn.com/abstract=3575581 or http://dx.doi.org/10.2139/ssrn.3575581. Accessed 13 May 2020

Blaize, 2020, Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient, Emerg Infect Dis, 26, 10.3201/eid2607.201603

Koehler, 2020, COVID-19 Associated Pulmonary Aspergillosis, Mycoses, 10.1111/myc.13096

Lescure, 2020, Clinical and virological data of the first cases of COVID-19 in Europe: a case series, Lancet Infect Dis, 10.1016/S1473-3099(20)30200-0

van Arkel, 2020, COVID-19 Associated Pulmonary Aspergillosis, Am J Respir Crit Care Med, 10.1164/rccm.202004-1038LE

Koehler, 2019, Intensive care management of influenza-associated pulmonary aspergillosis, Clin Microbiol Infect, 25, 1501, 10.1016/j.cmi.2019.04.031

Schauwvlieghe, 2018, Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study, Lancet Respir Med, 6, 782, 10.1016/S2213-2600(18)30274-1

Hope, 2005, Laboratory diagnosis of invasive aspergillosis, Lancet Infect Dis, 5, 609, 10.1016/S1473-3099(05)70238-3

D'Haese, 2012, Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity, J Clin Microbiol, 50, 1258, 10.1128/JCM.06423-11

Meersseman, 2008, Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients, Am J Respir Crit Care Med, 177, 27, 10.1164/rccm.200704-606OC

Patterson, 2016, Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clin Infect Dis, 63, e1, 10.1093/cid/ciw326

Zhou, 2017, Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis, J Clin Microbiol, 55, 2153, 10.1128/JCM.00345-17

Wahidi, 2020, American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection, J Bronchology Interv Pulmonol, 10.1097/LBR.0000000000000681

Verweij, 2020, Diagnosing COVID-19-associated pulmonary aspergillosis, Lancet Microbe, 10.1016/S2666-5247(20)30027-6

Shu, 2010, Dual seasonal patterns for influenza, China, Emerg Infect Dis, 16, 725, 10.3201/eid1604.091578

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 99 Available from:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200428-sitrep-99-covid-19.pdf?sfvrsn=119fc381_2. Accessed 13 May 2020

Hunter, 2014, In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias, J Clin Epidemiol, 67, 897, 10.1016/j.jclinepi.2014.03.003

Richardson, 2020, Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area, JAMA, 10.1001/jama.2020.6775